Time to Second Doses in Children and Adolescents With Epilepsy Treated With Valtoco® (Diazepam Nasal Spray): Final Subgroup Results From a Phase 3, Open-Label, Repeat-Dose Safety Study

被引：0
|
作者：
Tarquinio, D.
Dlugos, D.
Wheless, J.
Desai, J.
Boro, A.
Rabinowicz, A.
Carrazana, E.
机构：
来源：
ANNALS OF NEUROLOGY | 2021年 / 90卷
关键词：
Epilepsy;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
230
引用
收藏
页码：S124 / S124
页数：1
相关论文
共 49 条
  • [1] Safety of Valtoco® (Diazepam Nasal Spray) in Children and Adolescents With Epilepsy: Final Subgroup Results From a Phase 3, Long-Term Open-Label, Repeat-Dose Safety Study
    Tarquinio, D.
    Dlugos, D.
    Wheless, J.
    Desai, J.
    Boro, A.
    Carrazana, E.
    Rabinowicz, A.
    [J]. ANNALS OF NEUROLOGY, 2021, 90 : S128 - S128
  • [2] Safety of diazepam nasal spray (Valtoco®) in patients with epilepsy: Final results from a phase 3, open-label, 12-month, repeat-dose safety study
    Wheless, James
    Sperling, Michael
    Liow, Kore
    Segal, Eric
    Hogan, Robert
    Tarquinio, Daniel
    Mauney, Weldon
    Desai, Jay
    Dlugos, Dennis
    Biton, Victor
    Cascino, Gregory
    Carrazana, Enrique
    Rabinowicz, Adrian
    [J]. EPILEPSIA, 2021, 62 : 146 - 147
  • [3] Time to Second Doses in Emergency Seizure Patients Treated With Valtoco® (diazepam nasal spray) Across 24 Hours: Subgroup Results From a Completed Phase 3, Open-label, Repeat Dose Safety Study
    Wheless, James
    Sperling, Michael
    Liow, Kore
    Segal, Eric
    Miller, Ian
    Hogan, R. Edward
    Tarquinio, Daniel
    Desai, Jay
    Dlugos, Dennis
    Biton, Victor
    Cascino, Gregory
    Rabinowicz, Adrian L.
    Carrazana, Enrique
    [J]. NEUROLOGY, 2021, 96 (15)
  • [4] Safety of Valtoco™ (NRL-1; Diazepam Nasal Spray) in Children and Adolescents with Epilepsy: Interim Subgroup Results from a Phase 3, Open-Label, 12-Month Repeat Dose Study
    Segal, E.
    Tarquinio, D.
    Miller, I
    Dlugos, D.
    Wheless, J.
    Carrazana, E.
    [J]. ANNALS OF NEUROLOGY, 2019, 86 : S71 - S71
  • [5] Safety Profile of Valtoco® (diazepam nasal spray) in Patients With Epilepsy: Final Results From a Phase 3, Open-Label, 12-Month Repeat Dose Safety Study
    Wheless, James
    Sperling, Michael
    Liow, Kore
    Segal, Eric
    Miller, Ian
    Hogan, R. Edward
    Tarquinio, Daniel
    Desai, Jay
    Dlugos, Dennis
    Biton, Victor
    Cascino, Gregory
    Carrazana, Enrique
    Rabinowicz, Adrian L.
    [J]. NEUROLOGY, 2021, 96 (15)
  • [6] Final results from a Phase 3, long-term, open-label, repeat-dose safety study of diazepam nasal spray for seizure clusters in patients with epilepsy
    Wheless, James W.
    Miller, Ian
    Hogan, R. Edward
    Dlugos, Dennis
    Biton, Victor
    Cascino, Gregory D.
    Sperling, Michael R.
    Liow, Kore
    Vazquez, Blanca
    Segal, Eric B.
    Tarquinio, Daniel
    Mauney, Weldon
    Desai, Jay
    Rabinowicz, Adrian L.
    Carrazana, Enrique
    [J]. EPILEPSIA, 2021, 62 (10) : 2485 - 2495
  • [7] Use of second doses of Valtoco (R) (diazepam nasal spray) across 24 hours after the initial dose for out-of-hospital seizure clusters: Results from a phase 3, open-label, repeat-dose safety study
    Sperling, Michael R.
    Wheless, James W.
    Hogan, R. Edward
    Dlugos, Dennis
    Cascino, Gregory D.
    Liow, Kore
    Rabinowicz, Adrian L.
    Carrazana, Enrique
    [J]. EPILEPSIA, 2022, 63 (04) : 836 - 843
  • [8] Lack of observed tolerance to diazepam nasal spray (Valtoco®) after long-term rescue therapy in patients with epilepsy: Interim results from a phase 3, open-label, repeat-dose safety study
    Cascino, Gregory D.
    Tarquinio, Daniel
    Wheless, James W.
    Hogan, R. Edward
    Sperling, Michael R.
    Liow, Kore
    Desai, Jay
    Davis, Charles
    Rabinowicz, Adrian L.
    Carrazana, Enrique
    [J]. EPILEPSY & BEHAVIOR, 2021, 120
  • [9] A 12-month, open-label, repeat-dose safety study of Valtoco™ (NRL-1, diazepam nasal spray) in patients with epilepsy: Interim report
    Sperling, Michael
    Hogan, Robert
    Biton, Victor
    Tarquinio, Daniel
    Carrazana, Enrique
    [J]. NEUROLOGY, 2019, 92 (15)
  • [10] Patient-reported experience with diazepam nasal spray for seizure clusters: exit survey results from a phase 3, open-label, repeat-dose safety study
    Penovich, Patricia
    Wheless, James
    Hogan, Robert
    Guerra, Cynthia
    Cook, David
    Carrazana, Enrique
    Rabinowicz, Adrian
    [J]. EPILEPSIA, 2021, 62 : 148 - 149
12345